BioHealth News

TEDCO Seed Funds Invest in Galen Robotics, Inc.

TEDCO Seed Funds Invest in Galen Robotics, Inc.

Galen Robotics, Inc. was the winner of the 2018 BioHealth Capital Region Crab Trap Competition COLUMBIA, Md. (June 27, 2023) – TEDCO, Maryland’s economic…

Read More
Emergent BioSolutions Announces CEO Transition

Emergent BioSolutions Announces CEO Transition

GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed the Board of Directors…

Read More
Celebrating Dr. Kurt Newman’s Remarkable Leadership at Children’s National Hospital and in Pediatric Healthcare

Celebrating Dr. Kurt Newman’s Remarkable Leadership at Children’s National Hospital and in Pediatric Healthcare

As Dr. Kurt Newman, President and CEO of Children’s National Hospital, prepares for retirement, BioHealth Innovation, Inc. (BHI) honors his exceptional contributions and visionary…

Read More
TEDCO Invests SSBCI Funds in Longeviti Neuro Solutions, LLC

TEDCO Invests SSBCI Funds in Longeviti Neuro Solutions, LLC

Maryland company focused on innovating solutions for complex brain surgeries COLUMBIA, Md. (June 26, 2023) – Jesse Christopher, Longeviti co-founder and CEOTEDCO, Maryland’s economic…

Read More
Linshom Medical Launches Clinical Study at Ohio State University Wexner Medical Center

Linshom Medical Launches Clinical Study at Ohio State University Wexner Medical Center

ANNAPOLIS, MARYLAND, UNITED STATES, June 20, 2023/EINPresswire.com/ -- The study, “Advanced Prediction of Respiratory Depression Episodes with Linshom Continuous Predictive Respiratory Monitoring (CPRM)” began…

Read More
Unveiling the Life Sciences Landscape: Insights from CBRE Experts on BioTalk with Rich Bendis

Unveiling the Life Sciences Landscape: Insights from CBRE Experts on BioTalk with Rich Bendis

Are you curious to discover how experts navigate the complex landscape of life sciences real estate? Want to stay ahead of the curve in…

Read More
Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First Successful Clinical Trial of RNA Cell Therapy in Autoimmunity

Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First Successful Clinical Trial of RNA Cell Therapy in Autoimmunity

Modifying patients’ T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy), a novel approach to treat myasthenia gravis and other autoimmune diseases.…

Read More
TEDCO Announces Investment into Astek Diagnostics

TEDCO Announces Investment into Astek Diagnostics

Maryland life sciences company fighting antibiotic resistance, one innovative tech at a timeCOLUMBIA, Md. (June 22, 2023) – TEDCO, Maryland’s economic engine for technology…

Read More
Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care

Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care

The transformational investment is one of the hospital’s largest donations ever. It will power discoveries and revolutionize care for children and families who receive…

Read More
Noble Life Sciences Receives Renewed Accreditation from AAALAC International for Continued Commitment to Ethical Animal Research

Noble Life Sciences Receives Renewed Accreditation from AAALAC International for Continued Commitment to Ethical Animal Research

Sykesville, Maryland – June 20, 2023Noble Life Sciences, a leading contract research organization in Maryland, is proud to announce that it has received renewed…

Read More
Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

GERMANTOWN, Md. , June 20, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives…

Read More
Frederick’s Veralox Names Jonathan Mow as Chief Executive Officer as the Company Advances Development of First-in-Class Therapies for Immune-Mediated Diseases in Conjunction with Financing

Frederick’s Veralox Names Jonathan Mow as Chief Executive Officer as the Company Advances Development of First-in-Class Therapies for Immune-Mediated Diseases in Conjunction with Financing

— New Financing of $24 Million Fully Funds the Phase 2 Clinical Program for Lead Candidate VLX- 1005 — Company Prepares to Evaluate VLX-1005…

Read More
WBJ: Montgomery County biotechs are making scientific breakthroughs

WBJ: Montgomery County biotechs are making scientific breakthroughs

Countless medicines of tomorrow are being developed right here today — many in Montgomery County, among the country’s top life sciences hubs. Here’s a…

Read More
From Vision to Action: MEDCO’s Role in Economic Development and Partnerships on BioTalk with Rich Bendis

From Vision to Action: MEDCO’s Role in Economic Development and Partnerships on BioTalk with Rich Bendis

In this captivating episode of BioTalk, Rich Bendis sits down with Tom Sadowski, the Executive Director of the Maryland Economic Development Corporation (MEDCO). With…

Read More
NIH Releases Licensing Public Health & Economic Impact Study

NIH Releases Licensing Public Health & Economic Impact Study

The long-anticipated intramural licensing impact study was officially released in conjunction with the BIO Annual Meeting and is now posted to a special section…

Read More